Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,007 hedge funds and large institutions have $35.8B invested in Allergan plc in 2018 Q4 according to their latest regulatory filings, with 127 funds opening new positions, 280 increasing their positions, 486 reducing their positions, and 175 closing their positions.
6% less funds holding
Funds holding: 1,067 → 1,007 (-60)
12% less call options, than puts
Call options by funds: $745M | Put options by funds: $846M
27% less first-time investments, than exits
New positions opened: 127 | Existing positions closed: 175
31% less capital invested
Capital invested by funds: $51.7B → $35.8B (-$15.9B)
33% less funds holding in top 10
Funds holding in top 10: 49 → 33 (-16)
42% less repeat investments, than reductions
Existing positions increased: 280 | Existing positions reduced: 486
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
Longview Partners
St Peter Port,
Guernsey
|
+$734M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$520M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$407M |
| 4 |
KSCM
King Street Capital Management
New York
|
+$207M |
| 5 |
Renaissance Technologies
New York
|
+$132M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIG
Senator Investment Group
New York
|
-$248M |
| 2 |
GCM
Glenview Capital Management
New York
|
-$240M |
| 3 |
JP Morgan Chase
New York
|
-$183M |
| 4 |
State Street
Boston,
Massachusetts
|
-$171M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$156M |
AGN Hedge Fund Activity: Q4 2018 in Review
1,007 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q4 2018, worth a combined $35.8B — down 31% from $51.7B a quarter earlier.
Sellers outnumbered buyers: 175 funds closed out of AGN and 127 opened new positions — a net loss of 48 holders — while 486 trimmed existing stakes and 280 added.
The largest buyer was Longview Partners, adding an estimated $734M. The largest seller was Senator Investment Group, exiting entirely with an estimated $248M sold.
- 1,007 institutional investors held Allergan plc (AGN) as of Q4 2018, down from 1,067 in Q3 2018.
- Funds reported $35.8B of Allergan plc stock for Q4 2018, down 31% quarter-over-quarter.
- 127 funds opened new Allergan plc positions in Q4 2018 and 175 closed out, a net change of -48 holders.
- The largest Allergan plc buyer in Q4 2018 was Longview Partners, an estimated $734M added.
- The largest Allergan plc seller in Q4 2018 was Senator Investment Group, an estimated $248M sold.
Based on aggregated 13F filings for Q4 2018.